Clinical Trial

Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa

Name: Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa — clinical trial record (NCT07689188)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ARQ-MA-000260

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study investigates the efficacy of topical roflumilast foam in patients with HS.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-07.

Trial Details

NCT Number	NCT07689188
Lead Sponsor	Harrison Dermatology
Conditions	Hidradenitis Suppurativa (HS)
Enrollment	10 participants
Start Date	2026-08-10
Primary Completion	2028-03-10 (estimated)
Study Completion	2028-12-10 (estimated)
Updated on ClinicalTrials.gov	2026-07-09